Literature DB >> 8340445

Classroom academic performance: improvement with both methylphenidate and dextroamphetamine in ADHD boys.

J Elia1, P A Welsh, C S Gullotta, J L Rapoport.   

Abstract

Daily academic classroom performance was recorded in a day hospital school using a commonly employed reading and math series as part of an 11-week double-blind, placebo controlled, crossover comparison of dextroamphetamine (d-AMPH) and methylphenidate (MPH) in 33 hyperactive boys. Students attempted more math and reading tasks while on either active drug. The percent correct and the number of attempted problems of the reading series improved with both drugs while the percent correct for the math series occurred with d-AMPH only. No dose-response relationship was found for either stimulant. Moderate, transient adverse effects were common for both drugs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8340445     DOI: 10.1111/j.1469-7610.1993.tb01071.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  14 in total

1.  Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.

Authors:  Bjørn E Ramtvedt; Elisabeth Røinås; Henning S Aabech; Kjetil S Sundet
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-05-09       Impact factor: 2.576

2.  Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate.

Authors:  Bjørn E Ramtvedt; Henning S Aabech; Kjetil Sundet
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-03-25       Impact factor: 2.576

3.  Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.

Authors:  Sharon B Wigal; Tim Wigal; Sabrina Schuck; Matthew Brams; David Williamson; Robert B Armstrong; H Lynn Starr
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-04-13       Impact factor: 2.576

Review 4.  Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis.

Authors:  Sarah C O S Padilha; Suzane Virtuoso; Fernanda S Tonin; Helena H L Borba; Roberto Pontarolo
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-02-19       Impact factor: 4.785

5.  Reading and spelling deficits among children attending a psychiatric day treatment program.

Authors:  S Kotsopoulos; S Walker; K Beggs; B Jones; A Kotsopoulos; P Patel
Journal:  Eur Child Adolesc Psychiatry       Date:  1996-06       Impact factor: 4.785

Review 6.  Impact of Attention-Deficit Hyperactivity Disorder on School Performance: What are the Effects of Medication?

Authors:  Raman Baweja; Richard E Mattison; James G Waxmonsky
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

7.  Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis.

Authors:  Stephen V Faraone; Jan Buitelaar
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-09-10       Impact factor: 4.785

8.  Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder.

Authors:  Philip Shaw; Wendy S Sharp; Meaghan Morrison; Kristen Eckstrand; Deanna K Greenstein; Liv S Clasen; Alan C Evans; Judith L Rapoport
Journal:  Am J Psychiatry       Date:  2008-09-15       Impact factor: 18.112

9.  Childhood and adolescent hyperactivity-inattention symptoms and academic achievement 8 years later: the GAZEL Youth study.

Authors:  C Galéra; M Melchior; J-F Chastang; M-P Bouvard; E Fombonne
Journal:  Psychol Med       Date:  2009-04-01       Impact factor: 7.723

Review 10.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.